title: Human insulin-like growth factor I receptor function in pituitary cells is suppressed by a dominant negative mutant.
abstract: Hybrid receptors were studied in GC rat pituitary cells overexpressing either wild-type 950Tyr (WT) human insulin-like growth factor I (IGF-I) receptors or mutant human IGF-I receptors truncated at position 952 in the beta subunit transmembrane region (952STOP). 125I-IGF-I binding was increased in both 950Tyr (WT) (14-fold) and truncated human IGF-I receptor (952STOP) stable transfectants (50-fold), when compared to untransfected cells that contained endogenous rat IGF-I receptors. Metabolic cell labeling followed by immunoprecipitation with monoclonal alpha and beta subunit-specific antibodies revealed the presence of hybrid rat/truncated human receptors, truncated transfected human receptors, and WT human IGF-I holotetramers. Both mutant and hybrid receptors were degraded slower than 950Tyr (WT) receptors (> 16 h). Despite their markedly increased ligand binding and prolonged receptor half-life, 952STOP transfectants failed to transduce the IGF-I signal to suppress growth hormone (GH). Also, they neither underwent autophosphorylation nor phosphorylated endogenous proteins. The expected suppression of GH by endogenous rat IGF-I receptors was completely abrogated in 952STOP transfectants (P < 0.001 compared to untransfected cells). Mutant 952STOP cells were therefore completely devoid of biological signaling to GH despite the presence of endogenous rat IGF-I receptors. Thus mutant IGF-I receptors block ligand-mediated endogenous rat IGF-I signaling by functioning as a dominant negative forming nonfunctional human/rat hybrid receptors. Defective IGF-I receptors may function therefore as dominant negative phenotypes which suppress normal receptor responses in pituitary cells.
authors.affiliation: Department of Medicine, Cedars-Sinai Medical Center-UCLA School of Medicine 90048.
authors.forename: D
authors.initials: D
authors.lastname: Prager
authors.forename: H
authors.initials: H
authors.lastname: Yamasaki
authors.forename: M M
authors.initials: MM
authors.lastname: Weber
authors.forename: S
authors.initials: S
authors.lastname: Gebremedhin
authors.forename: S
authors.initials: S
authors.lastname: Melmed
mesh_terms: D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D006207:Half-Life; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D010766:Phosphorylation; D010902:Pituitary Gland / Q000737:chemistry*; D051381:Rats; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
chemical_list: D017526:Receptor, IGF Type 1